Our Vision

Our Vision

Our Vision

Improving maternal and fetal outcomes through innovative technology by transforming OB Ultrasound with AI in realtime

Improving maternal and fetal outcomes through innovative technology by transforming OB Ultrasound with AI in realtime

Improving maternal and fetal outcomes through innovative technology by transforming OB Ultrasound with AI in realtime

Make Obstretric screening accurate, safe, and less user-dependant

Every expectant parent deserves the reassurance of a precise and reliable obstetric screening, yet access to high-quality ultrasound diagnostics remains inconsistent worldwide. Variability in expertise, time constraints, and human error can lead to missed pathologies, delayed interventions, and unnecessary stress for families.

By making obstetric screening more accurate, safer, and less user-dependent, we envision a future where every pregnancy is monitored with the same level of precision—regardless of location or the clinician’s experience. Standardized, high-quality diagnostics mean earlier detection of complications, improved maternal and fetal outcomes, and a reduction in preventable adverse events.

A world where technology supports clinicians rather than replacing them is a world where expectant parents can trust that nothing will be overlooked. A world where healthcare professionals can focus on what truly matters: providing the best possible care for every mother and child.

Ivan’s Talking

“ At Diagnoly, we believe no parent or healthcare provider should experience uncertainty when it comes to mother-fetal care. Our aim is to bring greater security and peace of mind to mothers and caregivers, improve clinical outcomes, and be a trusted partner for all healthcare professionals.

We choose a longer and much more challenging road: to make a true real-time technology analyzing the live ultrasound scan. We believed that it was worth the effort, as this technology provides a secure way to analyze such complex fetal organs as heart and brain in the most complete way. ”

Ivan Voznyuk

Chief Executive Officer & Co-Founder

Our Journey

2021

The work has started with an access to first datasets

2021

The work has started with an access to first datasets

2021

The work has started with an access to first datasets

2022

Pre-seed funding secured, supported by the i-Lab grant

2022

Pre-seed funding secured, supported by the i-Lab grant

2022

Pre-seed funding secured, supported by the i-Lab grant

2024

FDA 510(k) clearance for fetal heart anatomy

2024

FDA 510(k) clearance for fetal heart anatomy

2024

FDA 510(k) clearance for fetal heart anatomy

2025

CE marking for fetal heart anatomy

2025

CE marking for fetal heart anatomy

2025

CE marking for fetal heart anatomy

2025

€5.5M seed funding round

2025

€5.5M seed funding round

2025

€5.5M seed funding round

Soon

FDA & CE certification for fetal brain

Soon

FDA & CE certification for fetal brain

Soon

FDA & CE certification for fetal brain

Smarter Ultrasound for
Better Outcomes

Discover how real-time AI can help you detect more and miss less—without changing the way you scan

Smarter Ultrasound for
Better Outcomes

Discover how real-time AI can help you detect more and miss less—without changing the way you scan

Smarter Ultrasound for
Better Outcomes

Discover how real-time AI can help you detect more and miss less—without changing the way you scan